Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Free cash flow margin

Free cash flow margin at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-77.4%+35.3pp
ALN
Alnylam PharmaceuticalsALNY
15%+12.7pp
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-9,777.6%-10,759pp
Beam Therapeutics logo
Beam TherapeuticsBEAM
-234%-86.6pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-106.8%-27.5pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-428.4%-214pp

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.13B+106%
Enterprise value$2.08B+100%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Calculated from Intellia Therapeutics’s reported figures.

free cash flow/total revenue=-550.2%

Based on trailing twelve months.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's free cash flow margin?
Intellia Therapeutics (NTLA) reported free cash flow margin of -550.2% in Q1 2026.
How has Intellia Therapeutics's free cash flow margin changed year-over-year?
Intellia Therapeutics's free cash flow margin increased by 34.2% year-over-year, from -836.4% to -550.2%.
What is the long-term trend for Intellia Therapeutics's free cash flow margin?
Over 5 years (2020 to 2025), Intellia Therapeutics's free cash flow margin has grown at a 44.7% compound annual growth rate (CAGR), from -92.2% to -585%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.